Lupus News

Despite a significant decrease in anxiety related to COVID-19, patients with autoimmune rheumatic disease continue to experience frequent interruptions in their medication use, according to survey data presented at ACR Convergence 2021.

Rheumatologists who prescribe hydroxychloroquine or chloroquine should be aware of their potential cardiac toxicity, especially in high-risk patients with rheumatic disease, according to an American College of Rheumatology white paper.

Hour-long, virtual exercise classes that cover Pilates, yoga and tai chi are safe and improved health outcomes in patients with musculoskeletal disease, according to data presented at ACR Convergence 2021.

The risk for hydroxychloroquine retinopathy increases with higher dosing per actual and ideal body weight, and with longer duration of use, according to data presented at ACR Convergence 2021.

A 300-mg dose of anifrolumab provided clinically meaningful benefit and was generally well-tolerated among patients with systemic lupus erythematosus, regardless of previous exposure to biologic agents, according to data presented at ACR Convergence 2021.

Hydroxychloroquine maintenance, compared with reducing or discontinuing, is associated with a lower risk for flare among patients with systemic lupus erythematosus in remission or very low disease activity, according to data presented here.

Unemployment and poverty can be significant drivers of poor outcomes in conditions like rheumatoid arthritis and systemic lupus erythematosus, according to a keynote lecture at ACR Convergence 2021.

Patients with systemic lupus erythematosus who have cognitive impairment demonstrate abnormal brain functional connectivity relative to patients without impairment and healthy controls, according to data presented at ACR Convergence 2021.

Data presented at ACR Convergence 2021 support the use of life-saving lung transplantation among qualified patients with systemic autoimmune diseases.

Managing oral, ocular and cutaneous complications is critical to optimizing outcomes in conditions ranging from Sjögren’s syndrome to juvenile dermatomyositis, according to a presenter who offered a cross-section of “pearls and myths” at ACR Convergence 2021.